Home | Links | Contact Us | More About Intellectual Property | Bookmark

Search patents:

Home

Gene Therapy

Low-aromatics-composition

Nucleoside analogs

OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the ...

Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof

To accomplish those objectives, the present invention provides hydrophobic muiticomponent heparin ...

Gas permeable bioreactor and method of use

OF THE PREFERRED EMBODIMENTS Like numbered apparatus elements in FIGS. 1-11 are the same. R...

Method for treating diseases of the inner ear using adamantane derivatives

OF THE INVENTION As already mentioned, the use of adamantane derivatives is possible or ...

Polyalkylene oxide-containing urethane polyols with sulphonic acid groups

What is claimed is: 1. Sulphonic acid group-containing polyalkylene oxide-containing urethane ...

Herpes treatment

I claim: 1. A method for the control of herpes virus infections in man which comprises contacting ...

Dense star polymers and dendrimers

OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is ...

Glycerin derivatives and inhibition of blood PAF

OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## ...

Oligonucleotide derivatives and production thereof

Gist In view of the state of the art as described above, the present inventors have developed an ...

Process for synthesizing macrocyclic chelates

The invention is a process for synthesizing a 12 membered ring tetraaza macromolecule. The process ...

Low aromatics composition

Details

Inventors: Vandermeiren, Herman;
Assignee:
Primary Examiner: Webb; Gregory
Assistant Examiner:
Attorney, Agent or Firm:

Provided is a composition comprising: (a) a hydrocarbon component; and (b) an ester component; wherein the composition has: (i) less than 13% vol. of aromatic compounds relative to the total volume of the composition; (ii) a distillation range situated within the range 135 260.degree. C.; and (iii) a Kauri butanol value of 34 or more.

DETAILED DESCRIPTION The inventions claimed is: 1.
A solvent composition comprising (a) a hydrocarbon component in an amount within the range of 91 99 vol.
% of said composition; and (b) an ester component in an amount within the range of 1 4 vol.
% of said composition; wherein the composition has: (c) less than 1 vol.
% of aromatic compounds relative to the total volume of the composition measured according to method ASTM D 1319; (i) a distillation range situated within the range 135 260.
degree.
C.
measured according to method ASTM D 86; and (ii) a Kauri butanol value of 34 or more measured according to method ASTMD 1133 wherein the hydrocarbon component comprises a de-aromatised hydrocarbon cut selected from the group consisting of white spirit and kerosene and mixtures thereof and wherein the hydrocarbon component has a distillation range situated within the range of 140 190.
degree.
C.
, 145 220.
degree.
C.
, 185 215.
degree.
C.
or 190 220.
degree.
C.
2.
A composition according to claim 1, which composition has a Kauri butanol value of 35 or more.
3.
A composition according to claim 1, which composition has a flashpoint of 38.
degree.
C.
or more.
4.
A composition according to claim 1, wherein the ester component comprises an ester of a mono-alcohol having from 6 12 carbon atoms, an ester of a poly-alcohol having from 4 8 carbon atoms, an ester of a hydroxyacid compound, or mixtures thereof.
5.
A composition according to claim 4, wherein the ester component comprises methyl caprylate and/or methyl heptanoate.
6.
A composition according to claim 1, wherein the ester component has a distillation range situated within the range of 145 220.
degree.
C.
7.
A process for the production of a solvent composition of: (a) a hydrocarbon component in an amount within the range of 91 99 vol.
% of said composition; and (b) an ester component in an amount within the range of 1 4 vol.
% of said composition; wherein the composition has: (c) less than 1 vol.
% of aromatic compounds relative to the total volume of the composition measured according to method ASTM D 1319; (i) a distillation range situated within the range 135 260

Related patents

	Covalently-linked complexes and methods for enhanced cytotoxicity and imaging The present invention describes a covalently-linked complex (CLC) for targeting a defined population of cells, comprising a targeting protein; a cytotoxic agent; and an ...
	Compositions and methods for drug delivery using pH sensitive molecules We claim: 1. A process for transfecting a nucleic acid into a cell in vivo, comprising: a) attaching a membrane activity inhibitor to a membrane active peptide via a ...
	Chiral peptide nucleic acid monomers and oligomers What is claimed is: 1. A peptide nucleic acid monomer having the formula: ##STR5## wherein: B is a naturally or non-naturally ocurring nucleobase; n is 0, 1, 2, or 3; ...
	Enzymatic DNA molecules The present invention thus contemplates a synthetic or engineered (i.e., non-naturally-occurring) catalytic DNA molecule (or enzymatic DNA molecule) capable of cleaving ...
	Multigene vectors The present invention provides a method for preparing HSV vectors. The method comprises co-transfecting a source vector and a mutating cassette together into a ...
	Composition and method for inhibiting platelet aggregation OF THE INVENTION This invention is provides a method of preventing or treating diseases or conditions associated with platelet aggregation. The method also provides a ...
	Nucleic acid probes OF THE INVENTION "Derivatizable" nucleotides are nucleotides modified so as to include at the 4-position of a pyrimidine a functional group which can react with a ...
	Assay for antiviral activity using complex of herpesvirus origin of replication and cellular protein The drawings are first described. FIG. 1 is a diagram of the HSV-1 genome and oriS. FIG. 1A indicates the locations of the three origins of DNA replication and the ...
	Substrate for detection of mammalian 5-C-DNA methyltransferase OF THE INVENTION "Oligomeric DNA" or ODN, as used herein, means a DNA having from 10 to 75 "purine or pyrimidine bases" connected in a series of nucleotides which are ...
	Vinyl ethers of nucleoside analogs OF THE INVENTION The compounds of the present invention can exist as optical isomers. Both the racemic and diasteromeric mixtures of these isomers which may exist for ...

0.024
Archive: All patents - Links Copyright (c)2006 Eipa-patents.org - All rights reserved